Answers are grounded in this paper and cite their sources.
The serum urate‐lowering effect of probenecid was used to monitor compliance in a placebo‐controlled study of prophylactic colchicine therapy for intercritical gout. Although all patients included in the analysis had satisfactory control of hyperuricemia, 20 patients receiving 1.5 mg of colchicine daily averaged 2.3 attacks of acute gout per year of therapy, compared to 18 placebo‐treated patients who averaged 6 attacks per year (P < 0.05), confirming the effectiveness of prophylactic colchicine in this situation.
No takes yet. Share an insight, caveat, or question.
Paulus et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: